MedPath
HSA Approval

LOMFLOX TABLET 400 mg

SIN10847P

LOMFLOX TABLET 400 mg

LOMFLOX TABLET 400 mg

March 31, 1999

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01MA07

lomefloxacin

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

IPCA LABORATORIES LTD

Active Ingredients

LOMEFLOXACIN HCl EQV LOMEFLOXACIN

400 mg

Lomefloxacin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LOMFLOX TABLET 400 mg - HSA Approval | MedPath